fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Asthma and why it causes deaths in the UK

Written by | 9 Jun 2022

Three deaths each day in the UK are due to asthma despite considerable advances in the understanding of the disease and the treatments available. IMI spoke to Dr… read more.

Dinitrophenol, nitrous oxide and the PHTA

Written by | 23 May 2022

Professor Gino Martini was recently appointed as the Chief Executive of the Precision Health Technologies Accelerator (PHTA) at Birmingham University. Previously he was Chief Scientist at the Royal… read more.

Opportunities for pharmacists

Written by | 22 May 2022

Experiences during the coronavirus pandemic have shown the real value of community pharmacy. Moreover, pharmacy can be seen as a ‘passport qualification’ that provides opportunities for pharmacists in… read more.

The Precision Health Technologies Accelerator

Written by | 21 May 2022

The Precision Health Technologies Accelerator (PHTA), a wholly-owned subsidiary of the University of Birmingham, will bring together innovators and entrepreneurs in life sciences and connect them with clinical… read more.

Taking action on nitrous oxide

Written by | 20 May 2022

Nitrous oxide has legitimate uses in the food industry and this makes its misuse difficult to combat, but proper checks at the time of purchase could reduce the… read more.

Nitrous oxide – spotting the problem

Written by | 19 May 2022

Nitrous oxide abuse appears to be widespread but it is far from harmless and prolonged use can lead to paralysis. Pharmacists need to raise awareness of the potentially… read more.

Dinitrophenol (DNP) misuse

Written by | 18 May 2022

Professor Gino Martini was recently appointed as the Chief Executive of the Precision Health Technologies Accelerator (PHTA) at Birmingham University. Previously he was Chief Scientist at the Royal… read more.

Sodium valproate – tackling the risks for pregnancy

Written by | 8 May 2022

A recent newspaper article drew attention to the increased risks of birth defects in children of mothers who have taken sodium valproate during pregnancy. In this series of… read more.

Next steps – improving safe use of medicines

Written by | 7 May 2022

The video-based medicines information project at Central & North West London (CNWL) NHS Foundation Trust builds on input from patients and carers and could be put to wider use,… read more.

Developing video information about sodium valproate

Written by | 6 May 2022

Emotionally engaging valproate information videos that can be accessed via QR codes have been developed in collaboration with patients and carers at Central & North West London (CNWL)… read more.

Tackling the risks with sodium valproate in pregnancy

Written by | 5 May 2022

The pregnancy prevention programme is critical for women who have to take valproate during pregnancy and it is bolstered by a battery of other measures, according Yogita Dawda,… read more.

Sodium valproate – the risks for pregnant women

Written by | 4 May 2022

A recent newspaper article drew attention to the increased risks of birth defects in children of mothers who have taken sodium valproate during pregnancy. IMI spoke to experienced… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.